Friday, 7 August 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 7 August 2026
IQVIA
IQVIA
Latest News
Doctors turn up heat on pharma

Australian doctors are exerting pressure on pharma to improve access to medicines - an added burden as the industry grapples with a failing HTA system and a Government dragging its feet on reform.

$170M franchise safe for a year
An injunction has prevented four drugs from facing first generic price cuts for at least another 12 months but the legal battle is far from over
TODAY
More to the story for patients
Pharma innovation has greatly extended the lifespan of people living with this disease, but now there are new challenges
TODAY
Most Popular
Pharma flags more job cuts
An ongoing 'cost base realignment' has been extended with more global redundancies but the impact on the local team is unknown
6 August
Ex-J&J boss lands 5th Country Leader job
Seasoned industry executive takes top job in expanding business with a growing portfolio of essential medicines
6 August
New rival to crash CAR-T market
A new CAR-T submitted to the TGA and MSAC looks set to take on Novartis' Kymriah and Gilead's Yescarta
6 August
After 8 OS deaths TGA reviews drug
With overseas regulators well down the path to removing this treatment from their market, the TGA has announced it's undertaking a review
4 August
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (21)

Access & Reimbursement (2)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (4)

Devices (1)

Executive Roles (2)

Other (13)

More News
Aussie peanut drug on fast track
Melbourne based company backed in part by the Novartis Future fund wins an FDA fast track for its peanut allergy immunotherapy
6 August
Diabetes drug restrictions gone
A big win for three companies with NZ's Pharmac extending access to their diabetes treatments to a further 30,000 Kiwis
6 August
Who's keeping eyes on rival Reps?
New service reveals which HCPs have interacted with competitor sales reps and it could be heading Down Under
5 August
Pharma exec up for Patient Choice gong
77 finalists across 15 categories selected by the patients, families, colleagues and communities who have experienced their work first-hand
5 August
The pharmacy of unavailable drugs
A powerful experience of being unable to access much-needed medicine is building public pressure for more drug funding
5 August
Who's moved to global HQ?
Two leaders promoted to new roles, one landing a regional gig while the other has moved to international headquarters
5 August
Backlash over PBAC monitoring
Pharma's unease with the PBAC's monitoring system of updated OS results of cancer drugs has been exposed in new documents
5 August
$300M blockbuster falls off patent
First time generic competition for half a dozen drugs, including a top seller, ushers in painful statutory price reductions
4 August
Who's jumped ship to be first CMO?
A pharma filling its first Chief Medical Officer position has landed an industry veteran with extensive experience in launching new indications
Deal paves way for global rollout
Exclusive license agreement for new cancer drug worth up to $601.9 million and covering 66 countries, including Australia
4 August
Med affairs, the time is now
A call to action has sounded: This cross-disciplinary team is urging a fundamental change to how Medical Affairs reach HCPs
4 August
Eight pharmas win PBS listings
A wave of PBS listings for August with more than half covering new medicines including the first new treatment option in 20 years
3 August
AZ, BMS in monster merger talks
A record-breaking pharmaceutical merger may be in the making, with AstraZeneca and BMS reportedly in talks
3 August
Will this drug finally reach Aust?
Four years on, this company is having another tilt at bringing its long-acting drug to Australia and it's actively pursing public funding
3 August
pif is changing
pif is changing
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe